See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI103.44▲ 3.99%
← 0YP5 page
XStocksXray
Market X-Ray report · 22 October 2026

Adyen NV (0YP5)

London Exchange · UK · prices in EUR · close of 22 Oct 2026

Key indicators

Last closeEUR 951.15
52-week range771.60 – 1,600.40
Return, 1 month / 3 months+5.4% / +14.6%
Return, 1 year / 3 years−37.2% / +38.5%
TrendBelow its 200-day average
RSI (14)59
Volatility (1 year)46.9%
Worst drawdown (1 year)-48.5%
Average daily value traded36.30M EUR
Dividend yield–

Market X-Ray price-based

44/ 100 · High confidence · ahead of 36% of stocks on this exchange
Trend37
Momentum45
Stability (higher is calmer)26
Liquidity83
Income–

Five-year price chart navy: price · brown: 200-day average

5041,1001,6972,2942,8902021-102023-012024-042025-072026-10

About the company

Adyen is a payments company based in Amsterdam that gives businesses a single platform for taking payments. It handles online payments, in-person card payments at physical locations, and payments made through mobile devices. Its customers are merchants, ranging from small shops to large international businesses, and it also offers related services such as fraud protection and payment data insights. The company connects merchants directly to card networks and local payment methods around the world.

The shares are listed on the London Exchange in UK under the code 0YP5, and the price on this page is in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Adyen NV (0YP5) trades on the London Exchange in UK. It last closed at EUR 951.15 on 22 October 2026.

Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 2,410 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 37.2% and over the last three months it rose 14.6%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Adyen NV (0YP5)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend37 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-1.3%
From 52-week high-37.9%
Momentum45 · WeakLagging most stocks on this exchange.
3-month return14.6%
6-month return-2.6%
12-month return, skipping the last month-40.4%
Stability (higher is calmer)26 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)46.9%
Worst drawdown, 1 year (smaller is calmer)-48.5%
Liquidity83 · StrongTrades actively.
Average daily value traded36.30M EUR
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week+0.9%
1 month+5.4%
3 months+14.6%
6 months−2.6%
1 year−37.2%
3 years+38.5%
5 years−64.6%

Signals

50-day / 200-day average955.15 / 963.70
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)25.21

Technical summary

DailyBullish9 bullish · 1 neutral · 6 bearish
WeeklyBearish4 bullish · 1 neutral · 7 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 23 Oct 2026